数学模拟评估α细胞失调在2型糖尿病进展中的作用
研究采用葡萄糖稳态生理模型,将葡萄糖、胰岛素和胰高血糖素的快速动态与β细胞功能质量(单个β细胞功能容量与质量的乘积)耦合,模拟不同程度α细胞失调对20年内β细胞功能质量及糖尿病进展的影响。结果显示轻度α细胞失调引发稳健的β细胞代偿,维持餐后血糖控制;中度失调初期增强代偿但最终加速2型糖尿病进展;α细胞失调影响空腹血糖、2小时血浆葡萄糖和HbA1c预测疾病发生时间的准确性。
要点
- 轻度α细胞失调可触发稳健β细胞代偿,维持餐后血糖正常。
- 中度α细胞失调初期增强代偿,但最终加速2型糖尿病进展。
- α细胞失调程度影响空腹血糖、2hPG和HbA1c预测发病时间的准确性。
核心结论
- 早期α细胞失调通过升高空腹血糖驱动稳健的β细胞功能质量代偿。
- α细胞失调进一步进展时,血糖升至糖毒性水平,加剧β细胞功能质量丧失并加速2型糖尿病发生。
研究设计与样本
- 研究建立葡萄糖稳态生理模型,耦合葡萄糖、胰岛素和胰高血糖素的快速动态与β细胞功能质量动态。
- 模型设定β细胞功能质量先代偿性增加,后因糖毒性下降;引入不同程度α细胞失调进行20年模拟。
- 模型通过视觉匹配已发表参数验证,参数来自正常血糖至2型糖尿病横断面队列的OGTT模型拟合。
主要发现
- 轻度α细胞失调引发稳健β细胞代偿,即使发生胰岛素抵抗仍控制餐后血糖波动。
- 中度α细胞失调初期增强代偿,但最终加速进展至2型糖尿病。
- α细胞失调影响空腹血糖、2小时血浆葡萄糖和HbA1c在疾病进展中的时间过程。
临床怎么用
- 提示α细胞失调程度可能影响空腹血糖、2hPG和HbA1c对2型糖尿病发病时间的预测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Alpha cell dysregulation is an integral part of type 2 diabetes pathophysiology, increasing fasting as well as postprandial glucose concentrations. Alpha cell dysregulation occurs in tandem with the development of insulin resistance and changes in beta cell function. Our aim was to investigate, using mathematical modelling, the role of alpha cell dysregulation in beta cell compensatory insulin secretion and subsequent failure in the progression from normoglycaemia to type 2 diabetes defined by ADA criteria. METHODS: We developed a physiological model of glucose homeostasis, whereby the fast dynamics of glucose, insulin and glucagon are coupled to the dynamics of beta cell functional mass (a product of individual beta cell functional capacity and mass). Beta cell functional mass exhibits an initial compensatory increase in response to hyperglycaemia, followed by an eventual decline due to glucotoxicity. Alpha cell dysregulation, defined as increased glucagon secretion and lowered glucagon suppression resulting in hyperglycaemia, was introduced to varying extents, and simulations were carried out to assess the effects on beta cell functional mass over a 20 year period. RESULTS: The simulations were carried out under conditions of moderate, mild or no alpha cell dysregulation. The parameters representing insulin resistance, glucagon secretion and suppression for an individual with normoglycaemia obtained from previously published work were evolved over a period of 20 years to the mean values observed in type 2 diabetes. The model was validated by visually matching the beta cell functional mass obtained from the simulations of the disease progression model to previously published parameters. Those parameters were obtained from fits of a model of OGTTs to data from a cross-sectional cohort that spanned the spectrum from normoglycaemia to type 2 diabetes. We found that mild alpha cell dysregulation elicited robust beta cell compensation, resulting in controlled postprandial glucose excursions despite the development of insulin resistance. Moderate alpha cell dysregulation initially enhanced compensation but eventually accelerated the progression to type 2 diabetes. Alpha cell dysregulation impacted the time course of the standard markers of diabetes (fasting glucose, 2 h plasma glucose and HbA1c) during disease progression. CONCLUSIONS/INTERPRETATION: The early stages of alpha cell dysregulation led to robust beta cell functional mass compensation driven by elevated fasting glucose. When the dysregulation progressed further, glucose levels rose to levels of glucotoxicity, exacerbating beta cell functional mass loss and accelerating the onset of type 2 diabetes. The various markers of diabetes (fasting glucose, 2 h plasma glucose and HbA1c) differed in terms of the prediction of timing of onset of disease, depending on the extent of alpha cell dysregulation.
引用
- Subramanian V, Sherman AS, Holst JJ, et al. Evaluating the role of alpha cell dysregulation in the progression to type 2 diabetes using mathematical simulations. Diabetologia. 2025. PMID: 40924110. doi:10.1007/s00125-025-06524-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。